483 Ajanta Pharma Jun 2019

483 Ajanta Pharma Jun 2019

Nicole Knowlton FDA, Jose Lopez Rubet FDA$119.00 - Available Now

FDA investigators audited the Ajanta Pharma - Aurangabad, India facility and issued inspectional observations (via FDA 483) on 28 Jun 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 28 Jun 2019
  • Location: Aurangabad, India
  • FEI: 3006785788
Add To Cart